AHA Letter on Drug Price Transparency Bill

AHA letter to Ways and Means Committee on the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113.

Key Resources

Related Resources

Testimony
AHA Testimony: Legislative Proposals To Increase Medicaid Access And Improve Program Integrity
Public
Letter/Comment
AHA Letter to Senate Finance Committee for May 1 Hearing on Change Healthcare Cyberattack
Letter/Comment
AHA Letter to House E&C Subcommittee for May 1 Hearing on Change Healthcare Cyberattack
Letter/Comment
AHA Urges More Congressional Action to Help Providers Affected By Change Healthcare Cyberattack
Public
Letter/Comment
AHA Urges Congress to Provide Support to Help Minimize Further Fallout from Change Healthcare Attack
Public
Letter/Comment
AHA Expresses Concerns with UHG Program in Response to Cyberattack on Change Healthcare
Public